Psychedelic drug may reduce anxiety and depression for terminal cancer patients
The medical community’s interest “is not about the drug per se, it’s about the experiences they generate.”
Keep readingHealth
Hot Topics
- January 12, 2020 | Recipes: Enjoy a Cuban-style dinner with paella
- January 10, 2020 | French pianist Lucas Debargue returns for Jan. 19 recital
- December 16, 2019 | Legally Speaking: When the Grinch wants to steal your holidays with the grandkids!
- December 13, 2019 | Lifelong Learning at McGill celebrates 30th anniversary
- December 12, 2019 | Editorial: Our vote reflects support for two-state solution
